Back

SGLT2 inhibitors on the prevention of contrast-induced acute kidney injury in patients with type 2 diabetes after coronary revascularization: a systematic review and meta-analysis

31 August 2025 (15:15 - 16:00)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (3) - Pharmacotherapy Cardiovascular Pharmacotherapy ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Kyriakos Dimitriadis

Hippokration General Hospital, Athens (Greece)

8 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Professor D. Bhatt (New York City, US)
Presentation thumbnail
Doctor P. Sun (Tianjin, CN)
Abstract Video
Presentation thumbnail
Doctor M. Galli (Rome, IT)
Abstract Video
Presentation thumbnail
Doctor M. Rahman (Flushing, US)
Abstract Video

Access the full session

Session thumbnail
New perspectives in cardiology (3) - Pharmacotherapy

The Event

Event poster

ESC Congress 2025

31 August 2025 15:15 CET
You may be interested in
thumbnail
Congress Presentation
The renal outcome post contrast exposure in patient with diabetes and SGLT2 inhibitor
thumbnail
Congress Presentation
SGLT2-'eyes' on the reno-protection prize: reduction of post-PCI contrast-associated AKI in diabetic patients using SGLT2 inhibitors
thumbnail
Congress Presentation
Impact of SGLT2-inhibitors on contrast-induced acute kidney injury in diabetic patients with acute myocardial infarction: data from SGLT2-I AMI PROTECT Registry

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources